Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  anti-CD3 immunotoxin A-dmDT390-bisFv(UCHT1)
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: FDA IND 100712, NCI-2014-00420, NCT00611208
Start Over